HKEX: 6819 - IntelliCentrics Global Holdings Ltd.

Yield per half year: 0%
Sector: Healthcare

IntelliCentrics Global Holdings Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 35.42 -100% -18.76 -100%
P/S 6.62 7.59 -12.76%
P/BV 337.41 3.68 9056.46%
P/FCF 0 55.3 -100%
Ev/Ebitda 478.09 2.91 16341.1%
Ev/S 54.37 23.72 129.27%
Ev/FCF 0 63.78 -100%
E/P -0.0031 0.0326 -109.5%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-14.85 -11.9 24.77% 8.84 -267.91%
ROE -97.24 5.19 -1974.87%
ROA -5.7 3.47 -264.29%
ROIC 0 0 0%
ROS -15.84 -11.49 37.9%
ROCE 0 6.04 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-10.7 0.7755 -1479.77% -16.84 -36.47%
Nеt Debt/Ebitda -2.43 0.0127 -19212.14%
Debt/Ratio 0.5103 0.1229 315.4%
Debt/Equity 1.1 0.802 37.07%
Debt/Net Income -4.79 1.76 -372.6%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
100.98 5.7 1671.64% 100.98 -0.0028%
Number of years of dividend growth 0 1.13 -100%
DSI 1 0.5838 71.29%
Average dividend growth 0 3.2 -100%
Average percentage for 5 years 100.98 4.95 1939.06%
Average percentage for payments 79.71 23.96 232.65%
Difference from average difference in sector 95.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
29.21 28.69 1.81%
Growth impulse Ebitda in 5 years -97.23 -40.52 139.96%
Growth impulse Net Income in 5 years -390.03 94.84 -511.25%
Growth impulse FCF in 5 years -149.07 91.41 -263.08%
Growth impulse EPS in 5 years -387.36 -118.14 227.88%
IP Score
4.09/10

Similar companies

Zai Lab Limited

JD Health International Inc.

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co. Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription